Open access · US-GOV
via ClinicalTrials.gov Clinical trial
VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity)
Authors not listed
Synbiotic Health · 2026
Abstract
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2026). VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity). <em>Synbiotic Health</em>. https://clinicaltrials.gov/study/NCT07407894
Vancouver
Anonymous. VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity). Synbiotic Health. 2026.
BibTeX
@misc{anon2026VITALA,
title = {VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity)},
author = {Anonymous},
journal = {Synbiotic Health},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
EUROPEAN LIFE SCIENCE RESEARCH ASSOCIATION 2026
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of NVTIA® Ergothioneine Supplementation on Healthy Aging Biomarkers and Skin Health in Healthy Adults
University of South Florida 2026
Open access · US-GOV
A Postbiotics Intervention to Improve Cognitive Function in Older Adults With Mild Cognitive Impairment (Phase 1)
Merck Sharp & Dohme LLC 2001
Open access · US-GOV
A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Oral Administration of Different Doses of Org 538 in Symptomatic Aging Men With Androgen Deficiency
Daehwa Pharmaceutical Co., Ltd. 2016
Open access · US-GOV
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IIb, Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)
ReCellience15, Inc 2027
Open access · US-GOV
A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects and Impacts of Supplemental Pentadecanoic Acid on Red Blood Cell Health and Activity and Predicted Biological Age in Healthy Older Adults
Frontiers in Genetics 2015
Open access · CC-BY